GSK granted US FDA fast track for gonorrhoea vaccine
(Alliance News) - GSK PLC on Tuesday reported that the US Food & Drug Administration has granted its gonorrhoea investigational vaccine a "fast track" designation.
Read moreMon, 12th Oct 2015 08:16
(Alliance News) - GSK PLC on Tuesday reported that the US Food & Drug Administration has granted its gonorrhoea investigational vaccine a "fast track" designation.
Read more(Sharecast News) - GSK said on Tuesday that its investigational vaccine for sexually transmitted infection gonorrhoea has been granted a fast track designation by the US Food and Drug Administration.
Read more(Alliance News) - Stock prices in London were set to open higher on Tuesday, following a positive session for equities in Hong Kong and Shanghai.
Read more(Alliance News) - GSK PLC on Monday celebrated several regulatory approvals for new drug therapies, including treatments for shingles.
Read more(Alliance News) - Stocks in London were set to start the new week marginally lower, with financial markets unfazed by a failed revolt by a mercenary army in Russia over the weekend.
Read more(Sharecast News) - GSK announced two significant advancements on Monday, with the approval of an updated indication for Shingrix in Japan, as well as a positive opinion from the European Medicines Agency for daprodustat.
Read moreGSK shares best performer on London's stock market
*Read more(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately reported by Alliance News:
Read moreSiemens Energy weighs on German stocks
*Read moreUK shoppers boost spending again in May
*Read more(Alliance News) - Stocks in London closed lower on Friday as weak economic data and the prospect of global interests staying higher for longer put investors in a firmly risk-off mood.
Read moreEuro zone business growth stalls in June -flash PMI
*Read more(Alliance News) - Stock prices in London were lower heading into Friday afternoon, as a poor week for equities continued, with investors fretting over the prospect of central banks keeping interest rates higher for longer.
Read moreWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .
‘DICTATOR? THAT’S ABSURD’: A GUIDE FOR INVESTORS NAVIGATING U.S.-CHINA TENSIONS (0915 GMT)Read moreWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .
PMIS IN FOCUS, HEALTHCARE STAVES OFF DEEPER LOSSES (0840 GMT)Read more